These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 18292165)
1. Doctors' education: the invisible influence of drug company sponsorship. Moynihan R BMJ; 2008 Feb; 336(7641):416-7. PubMed ID: 18292165 [TBL] [Abstract][Full Text] [Related]
2. Doctor takes "march of shame" to atone for drug company payments. Lenzer J; Brownlee S BMJ; 2008 Jan; 336(7634):20-1. PubMed ID: 18174595 [TBL] [Abstract][Full Text] [Related]
3. Cochrane at crossroads over drug company sponsorship. Moynihan R BMJ; 2003 Oct; 327(7420):924-6. PubMed ID: 14563759 [TBL] [Abstract][Full Text] [Related]
4. The pharmaceutical company and the academic medical center: win-win or mutual exploitation? Legato MJ J Gend Specif Med; 2002; 5(1):7-9. PubMed ID: 11859688 [No Abstract] [Full Text] [Related]
5. Pharmaceutical company funding and its consequences: a qualitative systematic review. Sismondo S Contemp Clin Trials; 2008 Mar; 29(2):109-13. PubMed ID: 17919992 [TBL] [Abstract][Full Text] [Related]
6. Matters arising from industry link to education. Mathew JL BMJ; 2008 Sep; 337():a1781. PubMed ID: 18812381 [No Abstract] [Full Text] [Related]
7. Individual drug firms should stop paying for medical education. Kmietowicz Z BMJ; 2009 Feb; 338():b442. PubMed ID: 19193684 [No Abstract] [Full Text] [Related]
8. Is the relationship between pharma and medical education on the rocks? Moynihan R BMJ; 2008 Aug; 337():a925. PubMed ID: 18703653 [No Abstract] [Full Text] [Related]
9. Who else but pharma will fund medical education? Ramogi MO BMJ; 2008 Sep; 337():a1778. PubMed ID: 18812379 [No Abstract] [Full Text] [Related]
10. Drug company sponsorship of education could be replaced at a fraction of its cost. Moynihan R BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595 [No Abstract] [Full Text] [Related]
11. Getting it right: industry sponsorship and medical research. Baird P CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071 [No Abstract] [Full Text] [Related]
12. Some progress in UK psychiatry. Moncrieff J; Thomas P; Huws R BMJ; 2008 Sep; 337():a1780. PubMed ID: 18812380 [No Abstract] [Full Text] [Related]
13. Influence of drug company authorship and sponsorship on drug trial outcomes. Tungaraza T; Poole R Br J Psychiatry; 2007 Jul; 191():82-3. PubMed ID: 17602130 [TBL] [Abstract][Full Text] [Related]
14. Pfizer stops funding medical education provided by profit making companies. Tanne JH BMJ; 2008 Jul; 337(7661):a708. PubMed ID: 18614497 [No Abstract] [Full Text] [Related]
15. Industry sponsorship and research outcome. Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689 [TBL] [Abstract][Full Text] [Related]
16. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
17. Association of Industry Sponsorship With Cancer Clinical Trial Accrual. Pasalic D; Tang C; Jagsi R; Fuller CD; Koong AC; Ludmir EB JAMA Oncol; 2020 Oct; 6(10):1625-1627. PubMed ID: 32815984 [TBL] [Abstract][Full Text] [Related]
18. [Sponsorship of continuing medical education]. Lundh A Ugeskr Laeger; 2007 Oct; 169(43):3681. PubMed ID: 17972396 [No Abstract] [Full Text] [Related]
19. Industry sponsorship and selection of comparators in randomized clinical trials. Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879 [TBL] [Abstract][Full Text] [Related]
20. Drug company merger should benefit research. Labreque G BMJ; 1998 Feb; 316(7130):494. PubMed ID: 9501704 [No Abstract] [Full Text] [Related] [Next] [New Search]